The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension
Open accessAbstract
Intensive care of patients with pulmonary hypertension (PH) and right-sided heart failure includes treatment of factors causing or contributing to heart failure, careful fluid management, and strategies to reduce ventricular afterload and improve cardiac function. Extracorporeal membrane oxygenation (ECMO) should be considered in distinct situations, especially in candidates for lung transplantation (bridge to transplant) or, occasionally, in patients with a reversible cause of right-sided heart failure (bridge to recovery). ECMO should not be used in patients with end-stage disease without a realistic chance for recovery or for transplantation. For patients with refractory disease, lung transplantation remains an important treatment option. Patients should be referred to a transplant centre when they remain in an intermediate- or high-risk category despite receiving optimised pulmonary arterial hypertension therapy. Meticulous peri-operative management including the intra-operative and post-operative use of ECMO effectively prevents graft failure. In experienced centres, the 1-year survival rates after lung transplantation for PH now exceed 90%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 Therapeutic approach to patients with severe right-sided heart failure. RV: right ventricular; PAH: pulmonary arterial hypertension; NO: nitric oxide; ECMO: extracorporeal membrane oxygenation; ECLS: extracorporeal lung support. Reproduced and modified from [80] with permission.](https://figures.cochat.ai/paper-figures/ec7f9b6c298d408b99223dc09199f5ea/intensive-care-right-ventricular-support-and-lung-transplantation-in-patients-figure-1.jpg)
![FIGURE 2 Effects on volume changes on cardiac function in right-sided heart failure. RV: right ventricle; LV: left ventricle; RVEDP: right ventricular end-diastolic pressure; TR: tricuspid regurgitation; CO: cardiac output. Reproduced and modified from [80] with permission.](https://figures.cochat.ai/paper-figures/e98ad229118d42d9a16db3d087540b1e/intensive-care-right-ventricular-support-and-lung-transplantation-in-patients-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Early consideration of transplant should be emphasized for patients with PAH, as referral of patients at the onset of clinical deterioration may not provide enough time to complete the evaluation and to obtain a suitable donor organ (275).”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [275]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationMullens, W., Abrahams, Z., Francis, G. S., Sokos, G., Taylor, D. O., Starling, R. C., Young, J. B., & Tang, W. H. W. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.068 · Cited by 1,674
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
Self-citationEndotoxin and immune activation in chronic heart failure: a prospective cohort study
Niebauer, J., Volk, H.-D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., & Anker, S. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09286-1 · Cited by 877
Heart-Lung Transplantation: Successful Therapy for Patients with Pulmonary Vascular Disease
Reitz, B. A., Wallwork, J. L., Hunt, S. A., Pennock, J. L., Billingham, M. E., Oyer, P. E., Stinson, E. B., & Shumway, N. E. (1982) · New England Journal of Medicine · doi:10.1056/nejm198203113061001 · Cited by 849
Harjola, V.-P., Mebazaa, A., Čelutkienė, J., Bettex, D., Bueno, H., Chioncel, O., Crespo-Leiro, M. G., Falk, V., Filippatos, G., Gibbs, S., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.478 · Cited by 720
Christie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Aurora, P., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., & Hertz, M. I. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.08.004 · Cited by 674
Hoeper, M. M., Kramer, T., Pan, Z., Eichstaedt, C. A., Spiesshoefer, J., Benjamin, N., Olsson, K. M., Meyer, K., Vizza, C. D., Vonk-Noordegraaf, A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00740-2017 · Cited by 660
Self-citationExtracorporeal Membrane Oxygenation in Awake Patients as Bridge to Lung Transplantation
Fuehner, T., Kuehn, C., Hadem, J., Wiesner, O., Gottlieb, J., Tudorache, I., Olsson, K. M., Greer, M., Sommer, W., Welte, T., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1599oc · Cited by 601
Self-citationBenza, R. L., Gomberg-Maitland, M., Miller, D. P., Frost, A., Frantz, R. P., Foreman, A. J., Badesch, D. B., & McGoon, M. D. (2012) · Chest · doi:10.1378/chest.11-0676 · Cited by 557 · cited 1×
“Thus, utilising risk stratification tools or scores ( i.e. REVEAL (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management) score ⩾ 10) [47]) that denote high-risk individuals may be particularly useful in deciding when to refer a patient for evaluation.”
Self-citationKylhammar, D., Kjellström, B., Hjalmarsson, C., Jansson, K., Nisell, M., Söderberg, S., Wikström, G., & Rådegran, G. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx257 · Cited by 540 · cited 1×
“Registry data suggest that the 1-year mortality rate of these patients is in fact >20% [45, 46].”
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Noordegraaf, A. V., Beghetti, M., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0242 · Cited by 511
Self-citationPrice, L. C., Wort, S. J., Finney, S. J., Marino, P. S., & Brett, S. J. (2010) · Critical Care · doi:10.1186/cc9264 · Cited by 389
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study
Sitbon, O., Jaïs, X., Savale, L., Cottin, V., Bergot, E., Macari, E. A., Bouvaist, H., Dauphin, C., Picard, F., Bulifon, S., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00116313 · Cited by 382 · cited 1×
“Initial triple combination therapy consisting of i.v. epoprostenol, oral phosphodiesterase type 5 inhibitors and endothelin receptor antagonists in patients with newly diagnosed PAH and right-sided heart failure has been reported with excellent short-term and mid-term results [20].”
Self-citationIschemic hepatitis: clinical presentation and pathogenesis
Seeto, R. K., Fenn, B., & Rockey, D. C. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00461-7 · Cited by 360
Hoeper, M. M., & Granton, J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0662ci · Cited by 316
Self-citationThe importance of the gastrointestinal system in the pathogenesis of heart failure
Krack, A., Sharma, R., Figulla, H. R., & Anker, S. D. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi389 · Cited by 280 · cited 2×
“…and congestion alter bowel wall permeability, and may cause translocation of bacteria and endotoxins from the bowel into the circulation resulting in a systemic inflammatory response or sepsis [4, 10, 11], which are common contributors to death in patients with right-sided heart failure [12].”
Effect of the lung allocation score on lung transplantation in the United States
Egan, T. M., & Edwards, L. B. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.01.010 · Cited by 270 · cited 1×
“With the introduction of the lung allocation score (LAS), waiting list mortality has decreased and the odds of receiving a donor organ have increased for most major lung diseases, including PAH [51, 52].”
Extracorporeal Membrane Oxygenation in Nonintubated Patients as Bridge to Lung Transplantation
Olsson, K. M., Simon, A., Strueber, M., Hadem, J., Wiesner, O., Gottlieb, J., Fuehner, T., Fischer, S., Warnecke, G., Kühn, C., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03192.x · Cited by 267
Self-citationPrognostic factors of acute heart failure in patients with pulmonary arterial hypertension
Sztrymf, B., Souza, R., Bertoletti, L., Jaïs, X., Sitbon, O., Price, L. C., Simonneau, G., & Humbert, M. (2010) · European Respiratory Journal · doi:10.1183/09031936.00070209 · Cited by 257 · cited 1×
“…and congestion alter bowel wall permeability, and may cause translocation of bacteria and endotoxins from the bowel into the circulation resulting in a systemic inflammatory response or sepsis [4, 10, 11], which are common contributors to death in patients with right-sided heart failure [12].”
Machuca, T. N., Collaud, S., Mercier, O., Cheung, M., Cunningham, V., Kim, S. J., Azad, S., Singer, L., Yasufuku, K., de Perrot, M., et al. (2015) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.11.039 · Cited by 248
Hoetzenecker, K., Schwarz, S., Muckenhuber, M., Benazzo, A., Frommlet, F., Schweiger, T., Bata, O., Jaksch, P., Ahmadi, N., Muraközy, G., et al. (2018) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.10.144 · Cited by 242 · cited 1×
“…has almost completely replaced the use of conventional cardiopulmonary bypass as it has been associated with a reduction of peri-operative complications including renal failure, a reduced need for transfusions of blood products and (in some, but not all, series) with better survival [49, 59 – 63].”
Self-citationUse of Central Venous Oxygen Saturation to Guide Therapy
Walley, K. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1584ci · Cited by 242 · cited 1×
“In addition, central venous oxygen saturation ( S cvO 2 ) measurements are important to determine tissue oxygenation as S cvO 2 correlates with cardiac output [13].”
Ghignone, M., Girling, L., & Prewitt, R. M. (1984) · Anesthesiology · doi:10.1097/00000542-198402000-00009 · Cited by 240
Cardiac hepatopathy: Clinical, hemodynamic, and histologic characteristics and correlations
Myers, R. P., Cerini, R., Sayegh, R., Moreau, R., Degott, C., Lebrec, D., & Lee, S. S. (2003) · Hepatology · doi:10.1053/jhep.2003.50062 · Cited by 238
Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation
Hoopes, C. W., Kukreja, J., Golden, J., Davenport, D. L., Diaz-Guzman, E., & Zwischenberger, J. B. (2013) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.12.022 · Cited by 234
Ius, F., Kuehn, C., Tudorache, I., Sommer, W., Avsar, M., Boethig, D., Fuehner, T., Gottlieb, J., Hoeper, M., Haverich, A., et al. (2012) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.07.095 · Cited by 222 · cited 1×
“…has almost completely replaced the use of conventional cardiopulmonary bypass as it has been associated with a reduction of peri-operative complications including renal failure, a reduced need for transfusions of blood products and (in some, but not all, series) with better survival [49, 59 – 63].”
Self-citationStrueber, M., Hoeper, M. M., Fischer, S., Cypel, M., Warnecke, G., Gottlieb, J., Pierre, A., Welte, T., Haverich, A., Simon, A. R., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02549.x · Cited by 219
Self-citationAtrial flutter and fibrillation in patients with pulmonary hypertension
Olsson, K. M., Nickel, N. P., Tongers, J., & Hoeper, M. M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.024 · Cited by 204 · cited 1×
“Supraventricular tachyarrhythmias, especially atrial flutter and atrial fibrillation, are common causes of right-sided heart failure in patients with severe PH [15] and rapid restoration of sinus rhythm should be attempted in such cases.”
Self-citationBermudez, C. A., Shiose, A., Esper, S. A., Shigemura, N., D’Cunha, J., Bhama, J. K., Richards, T. J., Arlia, P., Crespo, M. M., & Pilewski, J. M. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.06.072 · Cited by 183
Biscotti, M., Yang, J., Sonett, J., & Bacchetta, M. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.07.061 · Cited by 180
Tudorache, I., Sommer, W., Kühn, C., Wiesner, O., Hadem, J., Fühner, T., Ius, F., Avsar, M., Schwerk, N., Böthig, D., et al. (2015) · Transplantation · doi:10.1097/tp.0000000000000348 · Cited by 173
Self-citationHoetzenecker, K., Donahoe, L., Yeung, J. C., Azad, S., Fan, E., Ferguson, N. D., Del Sorbo, L., de Perrot, M., Pierre, A., Yasufuku, K., et al. (2018) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.09.161 · Cited by 164
Extracorporeal membrane oxygenation as a bridge to lung transplantation and recovery
Javidfar, J., Brodie, D., Iribarne, A., Jurado, J. E., LaVelle, M., BRENNER, K. R., Arcasoy, S. M., Sonett, J. R., & Bacchetta, M. D. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.05.040 · Cited by 162
Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension
Chen, H., Shiboski, S. C., Golden, J. A., Gould, M. K., Hays, S. R., Hoopes, C. W., & De Marco, T. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1603oc · Cited by 161 · cited 1×
“Still, the LAS does not always adequately reflect disease severity in patients suffering from PAH [53].”
Fadel, E., Mercier, O., Mussot, S., Leroy-Ladurie, F., Cerrina, J., Chapelier, A., Simonneau, G., & Dartevelle, P. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.02.039 · Cited by 159 · cited 1×
“To overcome this problem, several centres over many years have used combined heart and lung transplantation for patients with severe PH [66, 67].”
de Perrot, M., Granton, J. T., McRae, K., Cypel, M., Pierre, A., Waddell, T. K., Yasufuku, K., Hutcheon, M., Chaparro, C., Singer, L., et al. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.03.002 · Cited by 158
Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure*
Kerbaul, F., Rondelet, B., Demester, J.-P., Fesler, P., Huez, S., Naeije, R., & Brimioulle, S. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000242157.19347.50 · Cited by 156
Wickerson, L. M., Rozenberg, D., Janaudis‐Ferreira, T., Deliva, R. D., Lo, V., Beauchamp, G., Helm, D., Gottesman, C., Mendes, P. L., Vieira, L., et al. (2016) · World Journal of Transplantation · doi:10.5500/wjt.v6.i3.517 · Cited by 154
Pereszlenyi, A. (2002) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(02)00058-1 · Cited by 148 · cited 1×
“One of the most important innovations was the use of ECMO support during and after transplantation [58].”
Láng, G., Taghavi, S., Aigner, C., Renyi-Vamos, F., Jaksch, P., Augustin, V., Nagayama, K., Ghanim, B., & Klepetko, W. (2012) · Transplantation · doi:10.1097/tp.0b013e318246f8e1 · Cited by 137
Self-citationMoser, B., Jaksch, P., Taghavi, S., Muraközy, G., Láng, G., Hager, H., Krenn, C. G., Roth, G. A., Faybik, P., Bacher, A., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx212 · Cited by 136 · cited 4×
“Since the 1-year mortality after lung transplantation for severe PH in experienced centres is currently around 10% [48, 49], a survival benefit can be expected for such patients.”
InfluentialSelf-citationCongestive hepatic fibrosis score: a novel histologic assessment of clinical severity
Dai, D., Swanson, P. E., Krieger, E. V., Liou, I. W., Carithers, R. L., & Yeh, M. M. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.79 · Cited by 136
Hayanga, A. J., Aboagye, J., Esper, S. A., Shigemura, N., Bermudez, C. A., D’Cunha, J., & Bhama, J. K. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.08.072 · Cited by 135 · cited 1×
“The only established option for the use of ECLS in patients with PH and right-sided heart failure is bridge to transplantation (table 3) [36, 37].”
Organ Allocation Waiting Time During Extracorporeal Bridge to Lung Transplant Affects Outcomes
Crotti, S., Iotti, G. A., Lissoni, A., Belliato, M., Zanierato, M., Chierichetti, M., Meo, G. D., Meloni, F., Pappalettera, M., Nosotti, M., et al. (2013) · CHEST Journal · doi:10.1378/chest.12-1141 · Cited by 132
Held, M., Walthelm, J., Baron, S., Roth, C., & Jany, B. (2013) · European Respiratory Journal · doi:10.1183/09031936.00147712 · Cited by 113 · cited 1×
“Hypercapnic patients may benefit from non-invasive ventilation [16], although caution is necessary as even non-invasive ventilation may further impair right ventricular function [17].”
Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure*
Kerbaul, F., Gariboldi, V., Giorgi, R., Mekkaoui, C., Guieu, R., Fesler, P., Gouin, F., Brimioulle, S., & Collart, F. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000275266.33910.8d · Cited by 111
Extracorporeal Membrane Oxygenation Watershed
Hoeper, M. M., Tudorache, I., Kühn, C., Marsch, G., Hartung, D., Wiesner, O., Boenisch, O., Haverich, A., & Hinrichs, J. B. (2014) · Circulation · doi:10.1161/circulationaha.114.011677 · Cited by 108
Self-citationKasimir, M. (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.05.057 · Cited by 98
Rosenzweig, E. B., Brodie, D., Abrams, D. C., Agerstrand, C. L., & Bacchetta, M. D. (2013) · ASAIO Journal · doi:10.1097/mat.0000000000000021 · Cited by 85 · cited 1×
“Case reports demonstrating success of this approach are, however, rare [14, 41].”
Novel and Emerging Therapies for Pulmonary Hypertension
Pullamsetti, S. S., SCHERMULY, R. T., Ghofrani, H. A., Weißmann, N., Grimminger, F., & Seeger, W. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1543pp · Cited by 82 · cited 1×
“Reverse remodelling of the pulmonary vasculopathy is a main target of ongoing research, but success in human disease has been limited so far [72].”
Lung Transplantation in Germany Since the Introduction of the Lung Allocation Score
Gottlieb, J., Smits, J. M., Schramm, R., Langer, F., Buhl, R., Witt, C. C., Strueber, M., & Reichenspurner, H. C. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0179 · Cited by 77
Benza, R. L., Miller, D. P., Frost, A., Barst, R. J., Krichman, A. M., & McGoon, M. D. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e49b83 · Cited by 75 · cited 1×
“In a multivariable analysis comparing mortality predicted by the LAS system to actual mortality in REVEAL, two additional variables were independently associated with increased mortality compared with the LAS: mean right atrial pressure ⩾ 14 mmHg and 6-min walk distance ⩽ 300 m [54].”
Self-citationSchaffer, J. M., Singh, S. K., Joyce, D. L., Reitz, B. A., Robbins, R. C., Zamanian, R. T., & Mallidi, H. R. (2013) · Circulation · doi:10.1161/circulationaha.112.001080 · Cited by 69 · cited 1×
“With the introduction of the lung allocation score (LAS), waiting list mortality has decreased and the odds of receiving a donor organ have increased for most major lung diseases, including PAH [51, 52].”
Optimising the management of pulmonary arterial hypertension patients: emergency treatments
Delcroix, M., & Naeije, R. (2010) · European Respiratory Review · doi:10.1183/09059180.00004910 · Cited by 69 · cited 1×
“In such patients, a negative fluid balance should be sought by using i.v. loop diuretics or even haemofiltration [19].”
Growing Experience with Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation
Shafii, A. E., Mason, D. P., Brown, C. R., Vakil, N., Johnston, D. R., McCurry, K. R., Pettersson, G., & Murthy, S. C. (2012) · ASAIO Journal · doi:10.1097/mat.0b013e31826417d8 · Cited by 67
Punnoose, L., Burkhoff, D., Rich, S., & Horn, E. M. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.07.008 · Cited by 65 · cited 1×
“The role of this intervention is limited given the pathophysiology of PAH, which may include aggravation of pulmonary vascular remodelling, risk of pulmonary bleeding and induction of pulmonary oedema in patients with left ventricular diastolic dysfunction [32 – 34].”
Machuca, T., & de Perrot, M. E. (2015) · Circulation · doi:10.1161/circulationaha.114.012593 · Cited by 62
Extracorporeal membrane oxygenation as a bridge to lung transplantation: a long-term study†
Dellgren, G., Riise, G. C., Swärd, K., Gilljam, M., Rexius, H., Lidén, H., & Silverborn, M. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu112 · Cited by 61
Right ventricular recovery after bilateral lung transplantation for pulmonary arterial hypertension†
Gorter, T. M., Verschuuren, E. A. M., van Veldhuisen, D. J., Hoendermis, E. S., Erasmus, M. E., Bogaard, H. J., Noordegraaf, A. V., Berger, R. M. F., van Melle, J. P., & Willems, T. P. (2017) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivx025 · Cited by 59 · cited 1×
“Of note, almost any right ventricle recovers within a few weeks after transplantation, regardless of the degree of pre-transplant dilatation and dysfunction, and regardless of the severity of pre-operative tricuspid regurgitation [69 – 71].”
Glorion, M., Mercier, O. M., Mitilian, D., de Lemos, A., Lamrani, L., Feuillet, S., Pradère, P., Pavec, J. L., Lehouerou, D., Stéphan, F., et al. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy089 · Cited by 57
Self-citationGut–Lung Connection in Pulmonary Arterial Hypertension
Ranchoux, B., Bigorgne, A., Hautefort, A., Girerd, B., Sitbon, O., Montani, D., Humbert, M. J. C., Tchérakian, C., & Perros, F. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0404le · Cited by 57 · cited 2×
“…and congestion alter bowel wall permeability, and may cause translocation of bacteria and endotoxins from the bowel into the circulation resulting in a systemic inflammatory response or sepsis [4, 10, 11], which are common contributors to death in patients with right-sided heart failure [12].”
Olsson, K. M., Halank, M., Egenlauf, B., Fistera, D., Gall, H. J., Kaehler, C., Kortmann, K.-B., Kramm, T., Lichtblau, M., Marra, A. M., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.08.081 · Cited by 54
Self-citationLang, G., Ds, K., Aigner, C., Matilla, J. R., Taghavi, S., Jaksch, P., Muraközy, G., & Klepetko, W. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.07.009 · Cited by 49 · cited 1×
“The awake ECMO strategy has proven feasible, even with bridging times of several weeks [38], and has been associated with better outcomes than historical bridging strategies that included intubation and mechanical ventilation [14, 39, 40].”
Self-citationBı̂rsan, T., Kranz, A., Mares, P., Artemiou, O., Taghavi, S., Zuckermann, A. O., & Klepetko, W. (1999) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(98)00050-3 · Cited by 49
Self-citationFranke, U. F. W., Wiebe, K., Harringer, W., Franke, T., Wittwer, T., Wahlers, T., & Haverich, A. (2000) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(00)00525-x · Cited by 44
Sarkar, J., Golden, P., Kajiura, L. N., Murata, L. M., & UYEHARA, C. F. T. (2015) · Shock · doi:10.1097/shk.0000000000000325 · Cited by 44
Knight, D. S., Steeden, J. A., Moledina, S., Jones, A., Coghlan, G., & Muthurangu, V. (2015) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-015-0220-3 · Cited by 43 · cited 2×
“However, the notion that the small and “ unconditioned ” left ventricles of patients with severe PH are prone to developing diastolic dysfunction when exposed to a normal or high pre-load after transplantation only recently came into a wider focus of interest [32, 33, 48].”
Impact of high-priority allocation on lung and heart-lung transplantation for pulmonary hypertension
Savale, L., Le Pavec, J., Mercier, O., Mussot, S., Jaïs, X., Fabre, D., O’Connell, C., Montani, D., Stephan, F., Sitbon, O., et al. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.02.034 · Cited by 42 · cited 1×
“Some other countries not using the LAS have successfully implemented high-priority programmes for these patients [57].”
Self-citationScheurer, M. A., Bradley, S. M., & Atz, A. M. (2005) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.06.043 · Cited by 41 · cited 1×
“Vasopressin may be advantageous as it has pulmonary vasodilator effects [23, 24], but the clinical relevance of this property is unknown (table 2).”
Avriel, A., Klement, A. H., Johnson, S. R., de Perrot, M. E., & Granton, J. T. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14352 · Cited by 40 · cited 2×
“However, the notion that the small and “ unconditioned ” left ventricles of patients with severe PH are prone to developing diastolic dysfunction when exposed to a normal or high pre-load after transplantation only recently came into a wider focus of interest [32, 33, 48].”
State of the Art: Bridging to lung transplantation using artificial organ support technologies
Rajagopal, K., & Hoeper, M. M. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.10.005 · Cited by 36 · cited 2×
“…1) if conventional treatment strategies fail in patients who 2) have already been fully evaluated for lung transplantation, who 3) have a realistic chance of receiving a donor organ in a reasonable time frame and who 4) can still be expected to have a good outcome after transplantation [26].”
Self-citationPredictors of cardiac hepatopathy in patients with right heart failure
Megalla, S., Holtzman, D., Aronow, W. S., Nazari, R., Korenfeld, S., Schwarcz, A. I., Goldberg, Y. H., & Spevack, D. M. (2011) · Medical Science Monitor · doi:10.12659/msm.881977 · Cited by 35
Sarashina, T., Nakamura, K., Akagi, S., Oto, T., Oe, H., Ejiri, K., Nakagawa, K., Nishii, N., Matsubara, H., Kobayashi, M., et al. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-0838 · Cited by 33 · cited 1×
“Of note, almost any right ventricle recovers within a few weeks after transplantation, regardless of the degree of pre-transplant dilatation and dysfunction, and regardless of the severity of pre-operative tricuspid regurgitation [69 – 71].”
Rosenzweig, E. B., Chicotka, S. R., & Bacchetta, M. D. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.07.010 · Cited by 29 · cited 1×
“There are sporadic reports on isolated right ventricular assist device (RVAD) support in PAH [31].”
EXTUBATION AND MYOCARDIAL ISCHEMIA
Wellwood, M., Aylmer, A. P., Teasdale, S. J., Fremes, S. E., Ivanov, J., Madonik, M. M., Seawright, S. J., Mickle, D. A. G., & Weisel, R. D. (1984) · Anesthesiology · doi:10.1097/00000542-198409001-00132 · Cited by 28
Two axial-flow Synergy Micro-Pumps as a biventricular assist device in an ovine animal model
Schmitto, J. D., Burkhoff, D., Avsar, M., Fey, O., Ziehme, P., Büchler, G., Haverich, A., & Strueber, M. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.08.008 · Cited by 19 · cited 1×
“Smaller-sized devices with good ability to control the pump flow in the pulmonary circulation may open new options in the future [35].”
Low-flow support of the chronic pressure–overloaded right ventricle induces reversed remodeling
Verbelen, T., Claus, P., Burkhoff, D., Driesen, R. B., Nagaraju, C. K., Verbeken, E. K., Sipido, K. R., Delcroix, M., Rega, F., & Meyns, B. P. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.09.014 · Cited by 19 · cited 1×
“The veno-arterial configuration ensures rapid and effective unloading of the right ventricle [27].”
Kortchinsky, T., Mussot, S., Rezaiguia, S., Artiguenave, M., Fadel, É., & Stéphan, F. (2016) · Clinical Transplantation · doi:10.1111/ctr.12805 · Cited by 14 · cited 1×
“Today, however, the post-operative prolongation of veno-arterial ECMO after transplantation effectively prevents primary graft dysfunction [48, 68].”
Olsson, K. M., Frank, A. K., Fuge, J., Welte, T., Hoeper, M. M., & Bitter, T. (2015) · Respiratory Research · doi:10.1186/s12931-015-0298-z · Cited by 12 · cited 1×
“Hypercapnic patients may benefit from non-invasive ventilation [16], although caution is necessary as even non-invasive ventilation may further impair right ventricular function [17].”
Self-citation
Cited by
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Self-citation2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Self-citationRisk stratification and medical therapy of pulmonary arterial hypertension
Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01889-2018 · Cited by 819
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
An overview of the 6th World Symposium on Pulmonary Hypertension
Galiè, N., McLaughlin, V. V., Rubin, L. J., & Simonneau, G. (2019) · European Respiratory Journal · doi:10.1183/13993003.02148-2018 · Cited by 526
Metadata
- Authors
- Hoeper, M. M., Benza, R. L., Corris, P., de Perrot, M., Fadel, E., Keogh, A. M., Kühn, C., Savale, L., & Klepetko, W.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Allegheny General Hospital (US)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- UNSW Sydney (AU)
- Université Paris-Sud (FR)
- Medical University of Vienna (AT)
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801906
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351385
- OpenAlex
- W2904085911
- Semantic Scholar
- 0cb3e3a00226b18b6aafbe76418c4b8e0f8532ed
- Cited by
- 216
- References
- 81
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 22 · 2023: 35 · 2022: 38 · 2021: 40 · 2020: 34 · 2019: 11
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Mechanical Circulatory Support Devices
- Keywords
- pulmonary hypertension, right ventricular support, lung transplantation, extracorporeal membrane oxygenation, bridge to transplant, right heart failure, fluid management, afterload, transplant candidate selection, graft failure prevention, perioperative care, intensive care
- MeSH terms
- Animals, Antihypertensive Agents, Cardiac Output, Echocardiography, Heart Failure, Humans, Hypertension, Pulmonary, Intensive Care Units, Extracorporeal Membrane Oxygenation, Lung Transplantation, Ventricular Dysfunction, Right, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.